Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

News feed

Fifth line of the Amur Gas Processing Plant will start operating in November

9/4/25 GAZP

Rosneft to increase oil supplies to China by 2.5 million tons per year

9/4/25 ROSN

Belon reported for 6 months of 2025 in accordance with IFRS

9/3/25 BLNG

Shareholders of VseInstrumenti.ru approved dividends

9/3/25 VSEH

Ozon to build new logistics center in Yakutsk

9/3/25 OZON

Lenta has opened three supermarkets under the Platypus brand

9/3/25 LENT

Zvezda reported for 6 months of 2025 in accordance with IFRS

9/2/25 ZVEZ

Shareholders of Dorogobuzh approved dividends

9/2/25 DGBZ

GI-Solutions buys back Solidcore Resources shares at AIX price

9/2/25 POLY

Magnit is preparing to launch in the Magadan region

9/2/25 MGNT